Management recommendations to reduce cardiac risk in chronic epilepsy

Area of Science:

• Cardiology
• Neurology
• Clinical Management

Background:

• Chronic epilepsy is linked to increased cardiovascular disease (CVD) risk and premature cardiac death in adults.
• Pathophysiological mechanisms include accelerated atherosclerosis, myocardial infarction, autonomic dysfunction, heart failure, arrhythmias, and hyperlipidemia.
• Seizure-related catecholamine surges and hypoxia contribute to cardiac damage, termed 'Epileptic Heart'.

Purpose of the Study:

• To provide a systematic clinical management strategy for reducing cardiovascular disease risk in adult epilepsy patients.
• To highlight the importance of integrated cardiac care within epilepsy management.
• To offer guidance on monitoring and therapeutic adjustments.

Main Methods:

• Review of existing literature on epilepsy and cardiovascular comorbidities.
• Proposal of a management strategy incorporating cardiovascular risk guidelines.
• Emphasis on standard electrocardiographic and echocardiographic monitoring.
• Recommendation for regular assessment of plasma lipid profiles.

Main Results:

• Identification of specific cardiovascular risks associated with epilepsy.
• Acknowledgement of arrhythmogenic risks from sodium channel-blocking antiseizure medications (ASMs).
• Recognition that enzyme-inducing ASMs can elevate plasma lipid levels.

Conclusions:

• Implementing a structured approach to cardiac risk management is crucial for individuals with epilepsy.
• Careful consideration of antiseizure medications' cardiac effects is necessary.
• The ultimate goal is to mitigate cardiac risk and reduce premature mortality in this population.